Inogen to Present at 41st Annual J.P. Morgan Healthcare Conference
December 13 2022 - 4:00PM
Business Wire
Inogen, Inc. (Nasdaq: INGN), a medical technology company
offering innovative respiratory products for use in the homecare
setting, today announced that the company will be participating in
the upcoming 41st Annual J.P. Morgan Healthcare Conference.
Nabil Shabshab, President and Chief Executive Officer, is
scheduled to present on Wednesday, January 11, 2023, at 10:30 a.m.
Pacific Time.
A live webcast and archived recording of the presentation will
be available to all interested parties through the News / Events
page on the Inogen Investor Relations website.
Inogen has used, and intends to continue to use, its Investor
Relations website, http://investor.inogen.com/, as a means of
disclosing material non-public information and for complying with
its disclosure obligations under Regulation FD. For more
information, visit http://investor.inogen.com/.
About Inogen
Inogen is a medical technology company offering innovative
respiratory products for use in the homecare setting. The Company
primarily develops, manufactures, and markets innovative portable
oxygen concentrators used to deliver supplemental long-term oxygen
therapy to patients suffering from chronic respiratory
conditions.
For more information, please visit www.inogen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221213005897/en/
Agnes Lee ir@inogen.net
Inogen (NASDAQ:INGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Inogen (NASDAQ:INGN)
Historical Stock Chart
From Sep 2023 to Sep 2024